Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCLETIS-B

13.740
+1.84015.46%
Volume:18.61M
Turnover:248.80M
Market Cap:13.63B
PE:-41.79
High:13.950
Open:11.920
Low:11.890
Close:11.900
52wk High:18.750
52wk Low:1.480
Shares:992.00M
HK Float Shares:992.00M
Volume Ratio:2.81
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.329
ROE:-12.77%
ROA:-12.32%
PB:6.67
PE(LYR):-41.79
PS:5268.68

Loading ...

ASCLETIS-B (01672): Small Molecule GLP-1R Agonist ASC30's Ultra-Long-Acting Subcutaneous Depot Formulation for Weight Maintenance Demonstrates 75-Day Apparent Half-Life in Obese Subjects

Stock News
·
Sep 09

Ascletis Pharma Inc. Announces Phase IIa Study of ASC30 for Obesity Treatment with Promising Half-Life Results

Reuters
·
Sep 09

Hong Kong Stock Market Preview | Spot Gold Reaches $3,530, Southbound Capital's Annual Net Purchases Hit Record High

Stock News
·
Sep 03

Ascletis Pharma to Present Obesity Drug Study Data at Annual Diabetes Conference

MT Newswires Live
·
Sep 02

ASCLETIS-B (01672) to Present ASC30 Oral Small Molecule GLP-1R Agonist 28-Day Multiple Ascending Dose Study Results at 61st EASD Annual Meeting

Stock News
·
Sep 02

Ascletis Pharma Inc. Announces Presentation of ASC30 Clinical Trial Results at 61st EASD Annual Meeting

Reuters
·
Sep 02

ASCLETIS-B (01672): ASC30 Once-Daily Oral Tablets Demonstrate Favorable and Differentiated Pharmacokinetic Profile in US Phase Ib Multiple Ascending Dose Study

Stock News
·
Aug 28

Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of Asc30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study

THOMSON REUTERS
·
Aug 28

Ascletis Pharma Announces Promising Pharmacokinetic Results for ASC30 in U.S. Phase Ib Study

Reuters
·
Aug 28

HK Movers | Biotech Stocks Rise Against Trend, RemeGen Up 7%

Tiger Newspress
·
Aug 26

ASCLETIS-B (01672) Issues 28.82 Million Shares on August 25

Stock News
·
Aug 25

Ascletis Pharma Controlling Shareholder to Reduce Stake, Inject Fresh Capital via Share Transactions

MT Newswires Live
·
Aug 19

BUZZ-Ascletis Pharma falls most in 2 months on discounted share sale

Reuters
·
Aug 19

HK Movers | Ascletis Pharma Plummets 9% Due to 9.9% Discounted Top-Up Placement

Tiger Newspress
·
Aug 19

BRIEF-Ascletis Pharma Inc To Issue 28.8 Million New Shares

Reuters
·
Aug 19

Stock Track | Ascletis Pharma Plummets 9.64% Following Announcement of New Share Issuance

Stock Track
·
Aug 19

Ascletis Pharma Inc - to Issue 28.8 Mln New Shares at HK$16.45 per Share, Others

THOMSON REUTERS
·
Aug 19

Hong Kong Stock Alert | ASCLETIS-B (01672) Rises Over 3% as Interim Shareholder Losses Narrow 32.5% YoY, ASC30 US Phase Ib Study Shows Positive Data

Stock News
·
Aug 18

Stock Track | Ascletis Pharma Soars 5.07% on Promising Weight Loss Drug Combination Results

Stock Track
·
Aug 18

BRIEF-Ascletis Pharma Inc Says Combination Of Asc47 And Asc31 Shows Greater Weight Loss

Reuters
·
Aug 18